RBC Capital raised the firm’s price target on Leidos (LDOS) to $160 from $150 and keeps a Sector Perform rating on the shares. The company reported strong Q1 earnings beating consensus of $2.48, while revenue grew 7% and beat consensus by 4%, the analyst tells investors in a research note. The strong results reflected continued outperformance in Health & Civil in addition to the broader portfolio, RBC adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LDOS: